46 results on '"Eiring, A"'
Search Results
2. Platelet lamellipodium formation is not required for thrombus formation and stability
3. MM-281 Disparities in Multiple Myeloma Between Hispanics and Non-Hispanics–Real World Outcomes
4. miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response
5. shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance
6. BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships
7. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia
8. Zebrafish screen identifies novel compound with selective toxicity against leukemia
9. Sp1/NFκB/HDAC/ miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia
10. Secondary Genetic Events Impact the Expression of Key Immunotargets on the Surface of Multiple Myeloma Cells
11. The Role of G0S2 in Lipid Metabolism Regulation in Chronic Myeloid Leukemia
12. Differential CD38 Expression on Daratumumab-Naïve Vs. Resistant Multiple Myeloma - a Direct Stochastic Optical Reconstruction Microscopy ( dSTORM) Analysis in 53 Patients
13. Alloreactive (CD4-Independent) CD8+ T Cells Jeopardize Long-Term Survival of Intrahepatic Islet Allografts
14. Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis
15. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2–dependent suppression of C/EBPα-driven myeloid differentiation
16. Multiomic Analysis of CD38 Expression Levels in 209 Untreated and Daratumumab-Resistant Patients
17. Impaired Death Receptor Signaling Mediates Cross-Resistance to Immunotherapy in MM
18. 19S Proteasome Subunits As Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)
19. Regulation of Oxidative Energy Metabolism By G0S2 in FLT3+ AML
20. P-160: Disparities in multiple myeloma between hispanics and non-hispanics – real world outcomes
21. Synthesis of allysine ethylene acetal using phenylalanine dehydrogenase from Thermoactinomyces intermedius
22. Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border
23. NF-κB-Dependent Activation of the Proteasome Components, PSMD1 and PSMD3, As a Mechanism of Resistance to Imatinib
24. Poster: MM-281 Disparities in Multiple Myeloma Between Hispanics and Non-Hispanics–Real World Outcomes
25. Combining Dasatinib and AC220 Reduces Stroma-Based pSTAT5Y694 in FLT3-ITD+ AML and Overcomes FLT3 TKI Resistance
26. Selective Inhibition of Nucleocytoplasmic Transport Overcomes Ruxolitinib Resistance in Myelofibrosis
27. Inhibition of Nucleocytoplasmic Export Enhances Selective Elimination of Leukemic Stem Cells in Chronic Myeloid Leukemia
28. Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia
29. MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia
30. Limited Efficacy of BMS-911543 in a Murine Model of JAK2V617F Myeloproliferative Neoplasm
31. Design, Optimization, and Pre-Clinical Evaluation of Direct, Mechanism-Based STAT3 Inhibitors for Treating Myeloid Disorders
32. Next Generation Sequencing to Delineate the Mutational Landscape of Chronic Myelomonocytic Leukemia (CMML): Novel Disease Genes and Correlations with Survival
33. Direct Contact With Bone Marrow Stromal Cells Protects CML Progenitors From Imatinib Through Cytoplasmic Stabilization Of β-Catenin
34. An Unbiased shRNA Library Screen Identifies Nucleocytoplasmic Transport As a Potential Target For Treatment Of Chronic Myeloid Leukemia
35. STAT3 Inhibition Synergizes with BCR-ABL1 Inhibition to Overcome Kinase-Independent TKI Resistance in Chronic Myeloid Leukemia (CML)
36. Frequency and Clonality of BCR-ABL Compound Mutations in Chronic Myeloid Leukemia,
37. Intrinsic and Extrinsic Survival Signals Converge on STAT3 As a Critical Mediator of BCR-ABL-Independent Tyrosine Kinase Inhibitor Resistance,
38. Partially or Fully BCR-ABL Independent Mechanisms of in Vitro Resistance to Ponatinib
39. Requirement of the E2F3 Transcription Factor for BCR/ABL Leukemogenesis.
40. MicroRNAs Act as Decoy Molecules To Restore Granulocytic Maturation of Differentiation-Arrested BCR/ABL+ Myeloid Precursors.
41. Molecular and Pharmacologic Suppression of MAPK Activity Rescues Differentiation of BCR/ABL+ Myeloid Progenitors by Releasing C/EBPa from the Inhibitory Effect of hnRNP E2.
42. β-Adrenoceptor-linked protein kinase a (PKA) activity in human fibroblasts from normal subjects and from patients with major depression
43. Evaluation of Viability of Preserved Rabbit Corneas by Tissue Culture Procedures
44. Long-Term Preservation of Donor Tissues for Corneal Grafting : Correlation of results from tissue cultures with those from experimental graftings
45. Biochemically and immunologically active Zn2Mg alkaline phosphatase in archaeologically important bone samples
46. Morphologic and Histochemical Changes Occurring in Cat Corneas during Long-Term Glycerol Freezing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.